{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:33:59Z","timestamp":1776119639849,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015642","name":"Japan Lung Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["19K07733"],"award-info":[{"award-number":["19K07733"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.lungcan.2023.107264","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T11:50:17Z","timestamp":1685706617000},"page":"107264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors"],"prefix":"10.1016","volume":"181","author":[{"given":"Hirono","family":"Tsutsumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maako","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuto","family":"Yoneshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isamu","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8252-290X","authenticated-orcid":false,"given":"Eiji","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lungcan.2023.107264_b0005","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107264_b0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","article-title":"PAMPs and DAMPs: signal 0s that spur autophagy and immunity","volume":"249","author":"Tang","year":"2012","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.lungcan.2023.107264_b0015","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2023.107264_b0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/cdd.2013.84","article-title":"Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments","volume":"21","author":"Inoue","year":"2014","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107264_b0025","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1038\/s41467-018-06807-9","article-title":"Macrophages regulate the clearance of living cells by calreticulin","volume":"9","author":"Krysko","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.lungcan.2023.107264_b0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/cmi.2013.59","article-title":"TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells","volume":"11","author":"Fang","year":"2014","journal-title":"Cell. Mol. Immunol."},{"issue":"6673","key":"10.1016\/j.lungcan.2023.107264_b0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.lungcan.2023.107264_b0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.lungcan.2023.107264_b0045","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","article-title":"Immunological effects of conventional chemotherapy and targeted anticancer agents","volume":"28","author":"Galluzzi","year":"2015","journal-title":"Cancer Cell"},{"issue":"23","key":"10.1016\/j.lungcan.2023.107264_b0050","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1158\/1078-0432.CCR-19-0433","article-title":"The folate pathway inhibitor pemetrexed pleiotropically enhances effects of cancer immunotherapy","volume":"25","author":"Schaer","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.lungcan.2023.107264_b0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00262-012-1388-0","article-title":"Chemoimmunotherapy: reengineering tumor immunity","volume":"62","author":"Chen","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.lungcan.2023.107264_b0060","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.21037\/tlcr-21-92","article-title":"Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer","volume":"10","author":"Inoue","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"issue":"22","key":"10.1016\/j.lungcan.2023.107264_b0065","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non\u2013small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.lungcan.2023.107264_b0070","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1056\/NEJMoa1716948","article-title":"Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC","volume":"378","author":"Socinski","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.lungcan.2023.107264_b0075","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","article-title":"Pembrolizumab plus chemotherapy for squamous non\u2013small-cell lung cancer","volume":"379","author":"Paz-Ares","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.lungcan.2023.107264_b0080","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S1470-2045(19)30167-6","article-title":"Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial","volume":"20","author":"West","year":"2019","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2023.107264_b0085","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jtho.2020.11.025","article-title":"Atezolizumab plus chemotherapy for first-line treatment of nonsquamous NSCLC: results from the randomized phase 3 IMpower132 Trial","volume":"16","author":"Nishio","year":"2021","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107264_b0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/leu.2010.225","article-title":"HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells","volume":"25","author":"Liu","year":"2011","journal-title":"Leukemia"},{"issue":"16","key":"10.1016\/j.lungcan.2023.107264_b0095","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1158\/0008-5472.CAN-12-0851","article-title":"Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma","volume":"72","author":"Suzuki","year":"2012","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.lungcan.2023.107264_b0100","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.4049\/jimmunol.1000536","article-title":"Functional analysis of recombinant calreticulin fragment 39\u2013272: implications for immunobiological activities of calreticulin in health and disease","volume":"185","author":"Hong","year":"2010","journal-title":"J. Immunol."},{"issue":"Supplement","key":"10.1016\/j.lungcan.2023.107264_b0105","first-page":"S667","article-title":"Association of serum annexin A1 with treatment response and prognosis in patients with esophageal squamous cell carcinoma","volume":"14","author":"Han","year":"2018","journal-title":"J. Cancer Res. Ther."},{"issue":"4","key":"10.1016\/j.lungcan.2023.107264_b0110","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/MPA.0b013e3182374ace","article-title":"Serum HSP70: a novel biomarker for early detection of pancreatic cancer","volume":"41","author":"Dutta","year":"2012","journal-title":"Pancreas"},{"issue":"10","key":"10.1016\/j.lungcan.2023.107264_b0115","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1002\/art.27602","article-title":"Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells","volume":"62","author":"Tarr","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lungcan.2023.107264_b0120","doi-asserted-by":"crossref","first-page":"743050","DOI":"10.3389\/fonc.2021.743050","article-title":"CALR-TLR4 complex inhibits non-small cell lung cancer progression by regulating the migration and maturation of dendritic cells","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2023.107264_b0125","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1158\/0008-5472.CAN-15-1142","article-title":"Calreticulin expression in human non-small cell lung cancers correlates with increased accumulation of antitumor immune cells and favorable prognosis","volume":"76","author":"Fucikova","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2023.107264_b0130","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3389\/fimmu.2017.01034","article-title":"Calreticulin release at an early stage of death modulates the clearance by macrophages of apoptotic cells","volume":"8","author":"Osman","year":"2017","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.lungcan.2023.107264_b0135","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00262-021-03072-6","article-title":"Endoplasmic reticulum stress-induced release and binding of calreticulin from human ovarian cancer cells","volume":"71","author":"Abdullah","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107264_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.lungcan.2023.107264_b0145","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107264_b0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","article-title":"CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions","volume":"69","author":"Hashimoto","year":"2018","journal-title":"Annu. Rev. Med."},{"issue":"10","key":"10.1016\/j.lungcan.2023.107264_b0155","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/intimm\/dxm091","article-title":"Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs","volume":"19","author":"Wong","year":"2007","journal-title":"Int. Immunol."},{"issue":"9","key":"10.1016\/j.lungcan.2023.107264_b0160","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1158\/2326-6066.CIR-14-0191","article-title":"Identification and characterization of MEDI4736, an antagonistic anti-PD-L1 monoclonal antibody","volume":"3","author":"Stewart","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"17","key":"10.1016\/j.lungcan.2023.107264_b0165","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non\u2013small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"10027","key":"10.1016\/j.lungcan.2023.107264_b0170","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","article-title":"Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial","volume":"387","author":"Herbst","year":"2016","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.lungcan.2023.107264_b0175","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1\u2013positive non\u2013small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10066","key":"10.1016\/j.lungcan.2023.107264_b0180","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","article-title":"Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial","volume":"389","author":"Rittmeyer","year":"2017","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.lungcan.2023.107264_b0185","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMoa1917346","article-title":"Atezolizumab for first-line treatment of PD-L1-selected patients with NSCLC","volume":"383","author":"Herbst","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.lungcan.2023.107264_b0190","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.annonc.2021.04.008","article-title":"Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189","volume":"32","author":"Rodriguez-Abreu","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2023.107264_b0195","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.lungcan.2021.03.018","article-title":"Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non-small cell lung cancer","volume":"155","author":"Furukawa","year":"2021","journal-title":"Lung Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500223008024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500223008024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:07:01Z","timestamp":1759237621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500223008024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":39,"alternative-id":["S0169500223008024"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2023.107264","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2023.107264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107264"}}